TrialBMJ (Clinical research ed.)2026

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial.

Fei Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.